Pf-04531083
- Generic Name
- Pf-04531083
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H16ClN5O2
- CAS Number
- 1079400-07-9
- Unique Ingredient Identifier
- 40497CY7Y3
- Background
Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain.
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2012-01-19
- Last Posted Date
- 2013-06-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 90
- Registration Number
- NCT01512160
- Locations
- 🇺🇸
Pfizer Investigational Site, Austin, Texas, United States
A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2010-08-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT01119235
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2010-06-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT01103739
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04531083 In Healthy Male Subjects
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2009-12-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 80
- Registration Number
- NCT00992316
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath